Amplify Alternative Harve... (MJ)
Amplify Alternative Harvest ETF (MJ) Stock Price, Analysis & Data
Keine Daten verfügbar
| Geld | n/a |
| Marktkapitalisierung | n/a |
| Umsatz (TTM) | n/a |
| Nettogewinn (TTM) | n/a |
| Beta | n/a |
| EPS (ttm) | n/a |
| KGV (TTM) | n/a |
| Forward-KGV | n/a |
| KBV (TTM) | n/a |
| KUV (TTM) | n/a |
| Earnings Date | n/a |
| Brief | n/a |
| Volumen | 35,268 |
| Ø Vol. (20D) | 38,553 |
| Eröffnung | 25.01 |
| Vortagesschluss | 24.80 |
| Tagesspanne | 24.87 - 25.25 |
| 52-Wk Range | 21.05 - 46.75 |
| Analyst | n/a |
| Kursziel | n/a |
| Dividenden | n/a |
| Ex-Dividenden-Datum | n/a |
Über MJ
The fund will normally invest at least 80% of its net assets in the securities that comprise the index. The index seeks to provide exposure to global and U.S. companies that (i) engage in the cultivation, production, marketing or distribution of cannabis, including industrial hemp; and/or (ii) engage in the production, marketing, transportation or distribution of products containing cannabis, including industrial hemp, for medical or non-medical ...
Vollständiges UnternehmensprofilFinanzielle Entwicklung
Im Jahr undefined betrug der Umsatz von Amplify Alternative Harvest ETF n/a, ein Anstieg von undefined% im Vergleich zum Vorjahr (n/a). Der Gewinn lag bei n/a, ein Anstieg von undefined %.
Finanzberichte
vor 8 Monaten · Yahoo Finance Video
Tilray CEO says THC drink regulation will benefit cannabis companiesPresident Trump is expected to sign an executive order that could reclassify marijuana from a Schedule I to a Schedule III drug, which would enable cannabis to be federally classified for medical use....
